Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityDividends payablesLiabilities and Shareholders EquityLoans - Loss AllowanceLoans - NetMortgage LoansNon-Current DebtPayablesPrepaid AssetsReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Advanced Flower Capital (AFCG) Cash & Equivalents (2022 - 2025)

Advanced Flower Capital has reported Cash & Equivalents over the past 4 years, most recently at $38.6 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $38.6 million for Q4 2025, down 62.74% from a year ago — trailing twelve months through Dec 2025 was $38.6 million (down 62.74% YoY), and the annual figure for FY2025 was $38.6 million, down 62.74%.
  • Cash & Equivalents for Q4 2025 was $38.6 million at Advanced Flower Capital, down from $45.1 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for AFCG hit a ceiling of $170.3 million in Q2 2024 and a floor of $3.3 million in Q1 2025.
  • Median Cash & Equivalents over the past 4 years was $81.3 million (2023), compared with a mean of $75.8 million.
  • Biggest five-year swings in Cash & Equivalents: surged 107.48% in 2024 and later crashed 98.0% in 2025.
  • Advanced Flower Capital's Cash & Equivalents stood at $140.4 million in 2022, then plummeted by 35.61% to $90.4 million in 2023, then increased by 14.64% to $103.6 million in 2024, then crashed by 62.74% to $38.6 million in 2025.
  • The last three reported values for Cash & Equivalents were $38.6 million (Q4 2025), $45.1 million (Q3 2025), and $3.4 million (Q2 2025) per Business Quant data.